The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Repligen Corporation(NASDAQ:RGEN) 
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography r...
Website: http://www.repligen.com
Founded: 1981
Full Time Employees: 761
Sector: Healthcare
Industry: Medical Instruments & Supplies
Repligen Number of Twitter Followers
Repligen Days Payable Outstanding ttm (DPO)
Repligen Days Receivable Outstanding ttm (DSO)
Repligen Days Inventory Outstanding ttm (DIO)
Repligen Op Cashflow Per Share ttm
Repligen Free Cashflow Per Share ttm
Repligen Cash Per Share ttm
Repligen P/S ratio ttm
Repligen (GAAP) P/E ratio ttm
Repligen P/B ratio ttm
No extra charts and metrics for this ticker.